Citalopram hydrobromide 59729-32-7 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-16
Product Details
- Product NameCitalopram hydrobromide
- CAS No.59729-32-7
- EINECS No.261-890-6
- MFC20H22BrFN2O
- MW405.3
- AppearancepowderWhite
- Melting point 182-188°C
- storage temp. 2-8°C
- Water Solubility Soluble to 50 mM in ethanol and to 10 mM in water
Company Profile Introduction
Aruvi Labs is a 3 years 7 months old Proprietorship Firm incorporated on 03-Mar-2021, having its registered office located at 748/16, Ground Floor, Korattur, 28Th Street Tnhb Colony, Chennai, Tamil Nadu.
The major activity of Aruvi Labs is Services, Sub-classified into Scientific research and development and is primarily engaged in the Research and experimental development on natural sciences and engineering.
Aruvi Labs is classified as Micro enterprise in the financial year 2020-21. It has its unit situated at Chennai, Tamil Nadu.
Supplier other products
Recommended supplier
-
VIP1年
- SETV ASRV LLP
- 59729-32-7 CITALOPRAM HYDROBROMIDE 95-99%
- Inquiry
- 2024-09-11
-
VIP1年
- Raks Pharma Pvt Ltd
- 59729-32-7 99%
- Inquiry
- 2024-03-27
-
VIP1年
- Vijaya Pharma And Life Science
- 59729-32-7 Citalopram hydrobromide 98%
- Inquiry
- 2024-03-13
-
VIP0年
- Glyra Health Care Pvt Ltd
- Citalopram hydrobromide 99%
- Inquiry
- 2024-02-21
-
VIP1年
- Ralington Pharma
- 59729-32-7 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Raising Sun Pharma
- 59729-32-7 Citalopram hydrobromide 98%
- Inquiry
- 2024-02-03
-
VIP1年
- Kekule Pharma Limited
- Citalopram hydrobromide 59729-32-7 98%
- Inquiry
- 2024-01-31
-
VIP1年
- Rivashaa Agrotech Biopharma Pvt. Ltd.
- Citalopram hydrobromide 98%
- Inquiry
- 2024-01-25
-
VIP1年
- Valentis Laboratories Pvt. Ltd.
- 59729-32-7 98%
- Inquiry
- 2024-01-22
-
VIP1年
- Synergene Active Ingredients Pvt. Ltd.
- 59729-32-7 Citalopram hydrobromide 98%
- Inquiry
- 2024-01-17
- Since:2020-01-01
- Address: No.76A/1, SIDCO Industrial estate , 11th Street, Ambattur, Chennai, Tamil Nadu-600098, India.
INQUIRY